December 12, 2024

How Ordinary People Become Extraordinary Leaders

About the Organizer: Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California. Widely regarded as the world’s first biotechnology company, Genentech relentlessly pursues bold therapeutic ideas to improve outcomes for people with blood cancers and blood disorders.

About the Organizer: Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California. Widely regarded as the world’s first biotechnology company, Genentech relentlessly pursues bold therapeutic ideas to improve outcomes for people with blood cancers and blood disorders.

December 12, 2024

How Ordinary People Become Extraordinary Leaders

Discover the power of inner transformation in leadership.

At a pivotal end-of-year gathering in Dallas, Genentech invited Hitendra Wadhwa to deliver a 120-minute keynote for their team. Through storytelling, science, and real-world applications, Hitendra Wadhwa explained how ordinary individuals can access extraordinary leadership by activating their Inner Core.

About the Organizer: Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California. Widely regarded as the world’s first biotechnology company, Genentech relentlessly pursues bold therapeutic ideas to improve outcomes for people with blood cancers and blood disorders.

December 12, 2024

How Ordinary People Become Extraordinary Leaders

About the Organizer: Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California. Widely regarded as the world’s first biotechnology company, Genentech relentlessly pursues bold therapeutic ideas to improve outcomes for people with blood cancers and blood disorders.

December 12, 2024

How Ordinary People Become Extraordinary Leaders

December 12, 2024

How Ordinary People Become Extraordinary Leaders

December 12, 2024

How Ordinary People Become Extraordinary Leaders

December 12, 2024

How Ordinary People Become Extraordinary Leaders

About the Organizer: Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California. Widely regarded as the world’s first biotechnology company, Genentech relentlessly pursues bold therapeutic ideas to improve outcomes for people with blood cancers and blood disorders.

About the Organizer: Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California. Widely regarded as the world’s first biotechnology company, Genentech relentlessly pursues bold therapeutic ideas to improve outcomes for people with blood cancers and blood disorders.

December 12, 2024

How Ordinary People Become Extraordinary Leaders

About the Organizer: Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California. Widely regarded as the world’s first biotechnology company, Genentech relentlessly pursues bold therapeutic ideas to improve outcomes for people with blood cancers and blood disorders.

About the Organizer: Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California. Widely regarded as the world’s first biotechnology company, Genentech relentlessly pursues bold therapeutic ideas to improve outcomes for people with blood cancers and blood disorders.

December 12, 2024

How Ordinary People Become Extraordinary Leaders

December 12, 2024

How Ordinary People Become Extraordinary Leaders

About the Organizer: Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California. Widely regarded as the world’s first biotechnology company, Genentech relentlessly pursues bold therapeutic ideas to improve outcomes for people with blood cancers and blood disorders.

About the Organizer: Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California. Widely regarded as the world’s first biotechnology company, Genentech relentlessly pursues bold therapeutic ideas to improve outcomes for people with blood cancers and blood disorders.

December 12, 2024

How Ordinary People Become Extraordinary Leaders

About the Organizer: Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California. Widely regarded as the world’s first biotechnology company, Genentech relentlessly pursues bold therapeutic ideas to improve outcomes for people with blood cancers and blood disorders.

About the Organizer: Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California. Widely regarded as the world’s first biotechnology company, Genentech relentlessly pursues bold therapeutic ideas to improve outcomes for people with blood cancers and blood disorders.

December 12, 2024

How Ordinary People Become Extraordinary Leaders

About the Organizer: Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California. Widely regarded as the world’s first biotechnology company, Genentech relentlessly pursues bold therapeutic ideas to improve outcomes for people with blood cancers and blood disorders.

About the Organizer: Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California. Widely regarded as the world’s first biotechnology company, Genentech relentlessly pursues bold therapeutic ideas to improve outcomes for people with blood cancers and blood disorders.

December 12, 2024

How Ordinary People Become Extraordinary Leaders

About the Organizer: Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California. Widely regarded as the world’s first biotechnology company, Genentech relentlessly pursues bold therapeutic ideas to improve outcomes for people with blood cancers and blood disorders.

About the Organizer: Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California. Widely regarded as the world’s first biotechnology company, Genentech relentlessly pursues bold therapeutic ideas to improve outcomes for people with blood cancers and blood disorders.